Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Frohman

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Urology|February 18, 1999
Multiple sclerosis and the urologistS E Litwiller, E M Frohman, P E Zimmern
Journal of Clinical Immunology|January 1, 1989
Astrocytes and intracerebral immune responsesE M Frohman, S van den Noort, S Gupta
Annals of Neurology|April 1, 1996
Vestibular dysfunction in chronic inflammatory demyelinating polyneuropathyE M Frohman, R Tusa, A S Mark, et al.
Journal of Neuroimmunology|January 1, 1988
Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytesE M Frohman, B Vayuvegula, S van den Noort, et al.
Neurology|November 4, 2000
Assessment: prevention of post-lumbar puncture headaches: report of the therapeutics and technology assessment subcommittee of the american academy of neurologyR W Evans, C Armon, E M Frohman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanismsE M Frohman, B Vayuvegula, S Gupta, et al.
Journal of Clinical Immunology|May 3, 2001
Autonomic regulation of neuroimmunological responses: implications for multiple sclerosisE M Frohman, N L Monson, A E Lovett-Racke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniquesE M Frohman, P D Kramer, R B Dewey, et al.
Journal of the Neurological Sciences|December 1, 1988
Vasoactive intestinal polypeptide inhibits the expression of the MHC class II antigens on astrocytesE M Frohman, T C Frohman, B Vayuvegula, et al.
Neurology|November 26, 2003
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD S Goodin, B G Arnason, P K Coyle, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Urology|February 18, 1999
Multiple sclerosis and the urologistS E Litwiller, E M Frohman, P E Zimmern
Journal of Clinical Immunology|January 1, 1989
Astrocytes and intracerebral immune responsesE M Frohman, S van den Noort, S Gupta
Annals of Neurology|April 1, 1996
Vestibular dysfunction in chronic inflammatory demyelinating polyneuropathyE M Frohman, R Tusa, A S Mark, et al.
Journal of Neuroimmunology|January 1, 1988
Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytesE M Frohman, B Vayuvegula, S van den Noort, et al.
Neurology|November 4, 2000
Assessment: prevention of post-lumbar puncture headaches: report of the therapeutics and technology assessment subcommittee of the american academy of neurologyR W Evans, C Armon, E M Frohman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanismsE M Frohman, B Vayuvegula, S Gupta, et al.
Journal of Clinical Immunology|May 3, 2001
Autonomic regulation of neuroimmunological responses: implications for multiple sclerosisE M Frohman, N L Monson, A E Lovett-Racke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniquesE M Frohman, P D Kramer, R B Dewey, et al.
Journal of the Neurological Sciences|December 1, 1988
Vasoactive intestinal polypeptide inhibits the expression of the MHC class II antigens on astrocytesE M Frohman, T C Frohman, B Vayuvegula, et al.
Neurology|November 26, 2003
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD S Goodin, B G Arnason, P K Coyle, et al.
Pageof 5